Behcet's Disease Clinical Trial
Official title:
Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
Research into novel therapies for rare, immune-mediated inflammatory diseases (IMIDs) is limited due to small patient populations. Patients with Behçet's disease (BD), idiopathic inflammatory myopathy (IIM, also known as myositis) and IgG4-related disease (IgG4-RD) are treated with high-dosed glucocorticoids, methotrexate, azathioprine and mycophenolate mofetil, mostly for long periods of time with attendant risks of long-term toxicity, including infections. Therefore, there is an urgent need for new, more specific anti-inflammatory therapies such as targeted synthetic and biological disease-modifying antirheumatic drugs. Due to the role of type 1 interferon in both BD, IIM and IgG4-RD, JAK-STAT inhibition may be a promising treatment strategy in these conditions, because JAK1 is critical for the signal transduction of pro-inflammatory cytokine receptors. Previous research showed that JAK1 inhibition reduces activation of type 1 interferon-regulated proteins and key chemokines that control tissue inflammation.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05635266 -
A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
|
||
| Completed |
NCT02190916 -
Vasculitis Illness Perception (VIP) Study
|
N/A | |
| Completed |
NCT04065672 -
Low-dose IL-2 Treatment on Behcet's Disease
|
Phase 2 | |
| Recruiting |
NCT02593565 -
Vasculitis Pregnancy Registry
|
||
| Completed |
NCT00167583 -
Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)
|
Phase 3 | |
| Completed |
NCT03371095 -
Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
|
Phase 3 | |
| Completed |
NCT01960790 -
Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)
|
||
| Completed |
NCT03531385 -
Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Disease
|
||
| Completed |
NCT02190942 -
VCRC Patient Contact Registry Patient-Reported Data Validation Study
|
||
| Completed |
NCT04328064 -
The Role of Rosuvastatin on Vascular Involvement in Behçet's Disease
|
N/A | |
| Completed |
NCT02190929 -
Educational Needs of Patients With Systemic Vasculitis
|
N/A | |
| Completed |
NCT02476292 -
Impact of Vasculitis on Employment and Income
|
N/A | |
| Completed |
NCT03543709 -
Evaluation of Fibromyalgia With Disease Activity and Clinical Findings in Women With Behçet's Disease
|
||
| Recruiting |
NCT01793168 -
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
|
||
| Completed |
NCT01988506 -
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
|
Phase 2 | |
| Recruiting |
NCT01952275 -
Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
|
N/A | |
| Completed |
NCT01532570 -
Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions
|
Phase 3 | |
| Completed |
NCT03410290 -
Journey of Patients With Vasculitis From First Symptom to Diagnosis
|
||
| Completed |
NCT02176070 -
Reproductive Health in Men and Women With Vasculitis
|
N/A | |
| Recruiting |
NCT01306955 -
The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease
|
Phase 4 |